secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-12-16T23:59:59+00:00
Accession:  0001104659-25-121635
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma grants options and RSUs to five executives with $2.33 exercise price
--------------------------------------------------------------------------------

- Compensation Committee approved equity grants to CEO, CFO, CSO, CMO, and COO on December 12, 2025.
- CEO Iain Dukes receives 147,771 options + 36,943 RSUs; CFO Charles Parker receives 61,571 options + 15,393 RSUs.
- CSO C. David Pauza receives 73,886 options + 18,471 RSUs; CMO Robert Redfield receives 65,676 options + 16,419 RSUs.
- COO Nikolay Savchuk receives 65,676 options + 16,419 RSUs; all options have $2.33 strike, 10-year term, vest in 1 year.
- Grants made under the Amended and Restated 2021 Incentive Compensation Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925121635/0001104659-25-121635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925121635/tm2533625d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-121635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer